A spinoff company, Athira Pharma (formalized as M3 Biotechnology before rebranding), was founded in 2011 by PhD student Leen Kawas to commercialize dihexa and a related molecule, ATH-1017 (fosgonimeton)
Complete resolution of symptoms after one treatment was reported in 10 out of 12 patients, who rated their success at 100%
Ablation of catalase promotes non-alcoholic fatty liver via oxidative stress and mitochondrial dysfunction in diet-induced obese mice
[] Lycopene exerts its effects by regulating the expression of various genes that influence cell growth and survival
Summary of Benefits Skin brightening and beautifying effects Improvement of dark spots, dullness, and melasma Antioxidant effects (liver function improvement and protection) Anti-allergic effects (improvement of rough skin, dermatitis, and bronchial asthma) Treatment Details Treatment Flow For the treatment flow, please refer to this page .